Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yumiko Azuma

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Human Molecular Genetics|February 6, 2014
Identification of ter94, Drosophila VCP, as a strong modulator of motor neuron degeneration induced by knockdown of Caz, Drosophila FUSYumiko Azuma, Takahiko Tokuda, Mai Shimamura, et al.
Brain Research|December 23, 2018
Novel roles of Drosophila FUS and Aub responsible for piRNA biogenesis in neuronal disordersKeiko Tsuji Wakisaka, Ryo Tanaka, Tomoki Hirashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanomaYumiko Azuma, Yuji Ishikawa, Shigeto Kawai, et al.
Experimental Neurology|August 31, 2018
Genetic screening of the genes interacting with Drosophila FIG4 identified a novel link between CMT-causing gene and long noncoding RNAsYuuka Muraoka, Aya Nakamura, Ryo Tanaka, et al.
Experimental Cell Research|August 10, 2018
Hippo, Drosophila MST, is a novel modifier of motor neuron degeneration induced by knockdown of Caz, Drosophila FUSYumiko Azuma, Takahiko Tokuda, Yukie Kushimura, et al.
NPJ Parkinson'S Disease|June 27, 2017
Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do <i>PGK-1</i> mutations contribute to vulnerability to parkinsonism?Satoshi Sakaue, Takashi Kasai, Ikuko Mizuta, et al.
Nature Communications|September 7, 2022
Combination of T cell-redirecting bispecific antibody ERY974 and chemotherapy reciprocally enhances efficacy against non-inflamed tumoursYuji Sano, Yumiko Azuma, Toshiaki Tsunenari, et al.
Cell Reports. Medicine|November 29, 2025
Molecular subtypes of hepatocellular carcinoma linked to liver cell lineages and clinical outcomes of combination immunotherapyYulei Wang, Yinghui Guan, Alexander R Abbas, et al.
Cancer Immunology Research|April 1, 2024
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung CancerHirofumi Mikami, Shu Feng, Yutaka Matsuda, et al.
Science Translational Medicine|October 6, 2017
An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumorsTakahiro Ishiguro, Yuji Sano, Shun-Ichiro Komatsu, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Human Molecular Genetics|February 6, 2014
Identification of ter94, Drosophila VCP, as a strong modulator of motor neuron degeneration induced by knockdown of Caz, Drosophila FUSYumiko Azuma, Takahiko Tokuda, Mai Shimamura, et al.
Brain Research|December 23, 2018
Novel roles of Drosophila FUS and Aub responsible for piRNA biogenesis in neuronal disordersKeiko Tsuji Wakisaka, Ryo Tanaka, Tomoki Hirashima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanomaYumiko Azuma, Yuji Ishikawa, Shigeto Kawai, et al.
Experimental Neurology|August 31, 2018
Genetic screening of the genes interacting with Drosophila FIG4 identified a novel link between CMT-causing gene and long noncoding RNAsYuuka Muraoka, Aya Nakamura, Ryo Tanaka, et al.
Experimental Cell Research|August 10, 2018
Hippo, Drosophila MST, is a novel modifier of motor neuron degeneration induced by knockdown of Caz, Drosophila FUSYumiko Azuma, Takahiko Tokuda, Yukie Kushimura, et al.
NPJ Parkinson'S Disease|June 27, 2017
Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do <i>PGK-1</i> mutations contribute to vulnerability to parkinsonism?Satoshi Sakaue, Takashi Kasai, Ikuko Mizuta, et al.
Nature Communications|September 7, 2022
Combination of T cell-redirecting bispecific antibody ERY974 and chemotherapy reciprocally enhances efficacy against non-inflamed tumoursYuji Sano, Yumiko Azuma, Toshiaki Tsunenari, et al.
Cell Reports. Medicine|November 29, 2025
Molecular subtypes of hepatocellular carcinoma linked to liver cell lineages and clinical outcomes of combination immunotherapyYulei Wang, Yinghui Guan, Alexander R Abbas, et al.
Cancer Immunology Research|April 1, 2024
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung CancerHirofumi Mikami, Shu Feng, Yutaka Matsuda, et al.
Science Translational Medicine|October 6, 2017
An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumorsTakahiro Ishiguro, Yuji Sano, Shun-Ichiro Komatsu, et al.
Pageof 4